Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$9.4B
92M shares
52-week range
$74.38 – $105.48
89% from low
Exchange
NASDAQ
CS
Liberty Live Holdings Inc consists of its ownership in Live Nation, its wholly owned subsidiary Quint and other minority investments. Quint is a provider of premium sports and entertainment experiences. Through exclusive rights agreements with sports leagues, event organizers, and governing bodies, Quint designs, develops, and sells official ticket-inclusive hospitality and single to multi-day experiential packages that may include on or off-site experiences, transportation, and hotel accommodations, with involvement of Quint personnel throughout the multi-day experiences. Live Nation is one of the live entertainment companies in the world, and the producer of live music concerts in the world, based on total fans that attend Live Nation events as compared to events of other promoters.
www.libertyliveholdings.comNo one on the platform currently holds LLYVA.
No tracked institution reports a position in LLYVA as of their last filing.
No one on the platform has traded LLYVA yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
@WiTuLo @Blockchainsaw there is nobody who disputes the legitimacy of $CABA. It has been blessed by so many top pharma investors. The mega catalysts are just a little further away than they are in $SLS and the stock is priced commensurately. Now is the loading zone time and making the big money will require a little bit of patience as I don’t see it really hitting until 2028 or late 27. I was surprised that the significant investment of $LLYVA and Bain Capital Life Sciences among others did not provoke a giant run up in the share price. But it is what it is. The investment was a bit dilutive so that is probably why in the short term
View on StockTwits ↗$LLYVA trend with no friend. Love the base and the space. @howardlindzon
View on StockTwits ↗$LYV time for the $LLYVA algos to kick in and get that tape back to $172 so that the calls go up 100% (works every time)
View on StockTwits ↗$LLYVA Price: $94.45 (+1.35%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.28% RSI: 65.2 | Momentum: Strong Momentum Volume: +63.5% vs avg Volatility: 2.15% Support: $88.33 | Resistance: $98.61 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
View on StockTwits ↗$LLYVA Share Price: $93.59 Contract Selected: Nov 20, 2026 $95 Calls Buy Zone: $6.88 – $8.51 Target Zone: $12.57 – $15.36 Potential Upside: 72% ROI Time to Expiration: 192 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$LLYVA Q1 '26 Earnings Results & Recap Liberty Live anticipates recognizing approximately $7.48M in revenue from the delivery of performance obligations that extend beyond one year in the remainder of 2026.
View on StockTwits ↗$CABA recent history of $LLYVA , bio investments and acquisitions- last one: Apr. 2026 Ajax Therapeutics Lilly agreed to acquire Ajax for up to $2.3 billion. Lilly explicitly said it was a founding strategic investor in Ajax. Not CABA-like scientifically, but it is a strong precedent for Lilly converting a strategic investment into an acquisition. Bottom line - the investment by $LLY and Bain Capital Life Sciences is a transformational event in the history of $CABA. While it doesn’t mean that the clinical trials will succeed, it shows that the biggest names in the industry are getting involved and paying very close attention and if the trials are good, we could be staring at a massive buyout and a 10X or 20 X or more opportunity for the current shareholders who are buying in at this level. Companies like $LLY and Bain are extraordinarily selective in their investments and very serious $ do due diligence before making them. Insiders all bought $CABA and now giants did.
View on StockTwits ↗$LLYVA Q4 '25 Earnings Results & Recap Liberty Media's full year 2025 consolidated revenue increased to $4.48B, with operating income growing to $577 million and Adjusted OIBDA reaching $1,068 million, demonstrating robust financial performance.
View on StockTwits ↗$LLYVA Current Stock Price: $92.71 Contracts to trade: $80.0 LLYVA Mar 20 2026 Call Entry: $3.78 Exit: $5.77 ROI: 53% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗$LLYVA Share Price: $84.80 Contract Selected: May 15, 2026 $80 Calls Buy Zone: $2.80 – $3.46 Target Zone: $4.51 – $5.51 Potential Upside: 52% ROI Time to Expiration: 94 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$LLYVA is a media company with local TV and digital assets; its advertising revenue is cyclical and faces long-term secular pressure from cord-cutting.
View on StockTwits ↗$LLYVA Share Price: $81.99 Contract Selected: May 15, 2026 $80 Calls Buy Zone: $2.80 – $3.46 Target Zone: $5.28 – $6.45 Potential Upside: 78% ROI Time to Expiration: 105 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$LLYVA Current Stock Price: $84.29 Contracts to trade: $85 LLYVA Feb 20 2026 Call Entry: $1.80 Exit: $3.25 ROI: 81% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗$LLYVA Risk tolerance remains selective and tied closely to execution credibility. Operational cadence needs to tighten meaningfully. Any deterioration in traction could reset expectations abruptly. Without validation, volatility may persist longer than expected.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.